{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:42:10Z","timestamp":1781545330578,"version":"3.54.5"},"reference-count":176,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1097\/hrp.0000000000000018","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T15:26:57Z","timestamp":1409844417000},"page":"274-294","source":"Crossref","is-referenced-by-count":22,"title":["The Psychopharmacology Algorithm Project at the Harvard South Shore Program"],"prefix":"10.1097","volume":"22","author":[{"given":"Othman","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Osser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4088\/JCP.08m04663yel","article-title":"Neurocognitive impairment and psychosis in bipolar I disorder during early remission from an acute episode of mood disturbance.","volume":"71","author":"Levy","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R2-3-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/10673220903523524","article-title":"The psychopharmacology algorithm project at the Harvard South Shore Program: an update on bipolar depression.","volume":"18","author":"Ansari","year":"2010","journal-title":"Harv Rev Psychiatry"},{"key":"R3-3-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/HRP.0b013e31827fd915","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on schizophrenia.","volume":"21","author":"Osser","year":"2013","journal-title":"Harv Rev Psychiatry"},{"key":"R4-3-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/10673229.2011.614483","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder.","volume":"19","author":"Bajor","year":"2011","journal-title":"Harv Rev Psychiatry"},{"key":"R5-3-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/10673220802277904","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression.","volume":"16","author":"Hamoda","year":"2008","journal-title":"Harv Rev Psychiatry"},{"key":"R6-3-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.IDT.0000391328.04097.1e","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on generalized social anxiety disorder.","volume":"45","author":"Osser","year":"2010","journal-title":"Psychopharm Rev"},{"key":"R9-3-20210129","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4088\/JCP.09m05026gre","article-title":"Why do clinicians maintain antidepressants in some patients with acute mania Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.","volume":"71","author":"Rosa","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R11-3-20210129","doi-asserted-by":"crossref","first-page":"825","DOI":"10.4088\/JCP.v65n0614","article-title":"Psychosis in mania: specificity of its role in severity and treatment response.","volume":"65","author":"Swann","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R12-3-20210129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archpsyc.1973.01750320053009","article-title":"The stages of mania. A longitudinal analysis of the manic episode.","volume":"28","author":"Carlson","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"R13-3-20210129","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1017\/S1461145710001641","article-title":"Factors modifying drug and placebo responses in randomized trials for bipolar mania.","volume":"14","author":"Yildiz","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"R17-3-20210129","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0735-6757(97)90119-4","article-title":"Haloperidol, lorazepam, or both for psychotic agitation A multicenter, prospective, double-blind, emergency department study.","volume":"15","author":"Battaglia","year":"1997","journal-title":"Am J Emerg Med"},{"key":"R18-3-20210129","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1176\/ajp.146.12.1598","article-title":"Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation.","volume":"146","author":"Garza-Trevino","year":"1989","journal-title":"Am J Psychiatry"},{"key":"R19-3-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00213-006-0541-x","article-title":"Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.","volume":"188","author":"Andrezina","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"R20-3-20210129","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.4088\/JCP.v69n1204","article-title":"A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation.","volume":"69","author":"Satterthwaite","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R21-3-20210129","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.clinthera.2010.03.006","article-title":"Systematic reviews of assessment measures and pharmacologic treatments for agitation.","volume":"32","author":"Zeller","year":"2010","journal-title":"Clin Ther"},{"key":"R22-3-20210129","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/JCP.0b013e3182900fd6","article-title":"Are low doses of antipsychotics effective in the management of psychomotor agitation A randomized, rated-blind trial of 4 intramuscular interventions.","volume":"33","author":"Mantovani","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"R23-3-20210129","first-page":"CD007445","article-title":"Chlorpromazine for psychosis induced aggression or agitation.","author":"Ahmed","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R24-3-20210129","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jad.2007.12.001","article-title":"Delirious mania: clinical features and treatment response.","volume":"109","author":"Karmacharya","year":"2008","journal-title":"J Affect Disord"},{"key":"R25-3-20210129","first-page":"161","article-title":"Comorbid anxiety in bipolar spectrum disorders: a neglected research and treatment issue J Affect D","volume":"137","author":"Provencher","year":"2012","journal-title":"isord"},{"key":"R26-3-20210129","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2165\/00003495-200565090-00002","article-title":"Use of antipsychotics in the management of schizophrenia during pregnancy.","volume":"65","author":"Trixler","year":"2005","journal-title":"Drugs"},{"key":"R27-3-20210129","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1345\/aph.1D485","article-title":"Clinical utilization of atypical antipsychotics in pregnancy and lactation.","volume":"38","author":"Gentile","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R28-3-20210129","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/ajhp\/60.21.2253","article-title":"Maternal haloperidol therapy associated with dyskinesia in a newborn.","volume":"60","author":"Collins","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"R29-3-20210129","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/JCP.0b013e318172b8d5","article-title":"Maternal use of antipsychotics in early pregnancy and delivery outcome.","volume":"28","author":"Reis","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R31-3-20210129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.PSYPHR.0000428766.86387.f4","article-title":"Psychiatric care during pregnancy and postpartum. Part 1: diagnosis and management of mood disorders.","volume":"48","author":"McKean","year":"2013","journal-title":"Psychopharm Rev"},{"key":"R32-3-20210129","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","article-title":"Valproic acid monotherapy in pregnancy and major congenital malformations.","volume":"362","author":"Jentink","year":"2010","journal-title":"N Engl J Med"},{"key":"R33-3-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/adc.2009.176990","article-title":"Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.","volume":"96","author":"Cummings","year":"2011","journal-title":"Arch Dis Child"},{"key":"R34-3-20210129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.1994.03510260078033","article-title":"A reevaluation of risk of in utero exposure to lithium.","volume":"271","author":"Cohen","year":"1994","journal-title":"JAMA"},{"key":"R35-3-20210129","first-page":"444","article-title":"Use of electroconvulsive therapy during pregnancy.","volume":"45","author":"Miller","year":"1994","journal-title":"Hosp Community Psychiatry"},{"key":"R36-3-20210129","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1176\/appi.ajp.161.4.608","article-title":"Management of bipolar disorder during pregnancy and the postpartum period.","volume":"161","author":"Yonkers","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R37-3-20210129","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.","volume":"158","author":"McElroy","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R38-3-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/appi.ajp.2012.12010112","article-title":"Current status of co-occurring mood and substance use disorders: a new therapeutic target.","volume":"170","author":"Pettinati","year":"2013","journal-title":"Am J Psychiatry"},{"key":"R39-3-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.62.1.37","article-title":"Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study.","volume":"62","author":"Salloum","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R40-3-20210129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/JCP.0b013e31814db4c4","article-title":"A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence.","volume":"27","author":"Brown","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"R41-3-20210129","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1177\/0269881110376685","article-title":"Effects on prolongation of Bazetts corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis.","volume":"25","author":"Chung","year":"2011","journal-title":"J Psychopharmacol"},{"key":"R42-3-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1176\/appi.ajp.2012.12030301","article-title":"Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis.","volume":"170","author":"Swann","year":"2013","journal-title":"Am J Psychiatry"},{"key":"R43-3-20210129","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1017\/S1461145711001817","article-title":"Treatment of mixed bipolar states.","volume":"15","author":"Fountoulakis","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"R45-3-20210129","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.08m04895yel","article-title":"Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.","volume":"70","author":"Houston","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R46-3-20210129","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2013.02.031","article-title":"First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo.","volume":"150","author":"Suppes","year":"2013","journal-title":"J Affect Disord"},{"key":"R48-3-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1399-5618.2005.00197.x","article-title":"Pharmacotherapy of bipolar mixed states.","volume":"7","author":"Kruger","year":"2005","journal-title":"Bipolar Disord"},{"key":"R49-3-20210129","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"R50-3-20210129","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1517\/14656566.2012.681377","article-title":"Quetiapine for the treatment of acute bipolar mania, mixed episodes and maintenance therapy.","volume":"13","author":"Janicak","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"R51-3-20210129","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4088\/JCP.11m06878","article-title":"Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study).","volume":"72","author":"Weisler","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"R52-3-20210129","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.clinthera.2011.10.002","article-title":"Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.","volume":"33","author":"Cutler","year":"2011","journal-title":"Clin Ther"},{"key":"R53-3-20210129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-5618.2010.00815.x","article-title":"A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder.","volume":"12","author":"Vieta","year":"2010","journal-title":"Bipolar Disord"},{"key":"R54-3-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.pnpbp.2007.01.006","article-title":"Quetiapine dosage in bipolar disorder episodes and mixed states.","volume":"31","author":"Khazaal","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R55-3-20210129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004714-200304000-00005","article-title":"Acute dysphoric mania: treatment response to olanzapine versus placebo.","volume":"23","author":"Baker","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R56-3-20210129","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0165-0327(00)00313-X","article-title":"Use of olanzapine in dysphoric mania.","volume":"66","author":"Gonzalez-Pinto","year":"2001","journal-title":"J Affect Disord"},{"key":"R57-3-20210129","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1192\/bjp.bp.112.108357","article-title":"Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression.","volume":"201","author":"Tohen","year":"2012","journal-title":"Br J Psychiatry"},{"key":"R58-3-20210129","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1176\/ajp.2007.164.7.1050","article-title":"Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.","volume":"164","author":"McEvoy","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R59-3-20210129","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/JCP.0b013e31829e8333","article-title":"Acute effects of single-dose olanzapine on metabolic, endocrine, and inflammatory markers in healthy controls.","volume":"33","author":"Hahn","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"R60-3-20210129","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.","volume":"66","author":"Suppes","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R61-3-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania.","volume":"10","author":"Grunze","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"R62-3-20210129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jad.2009.06.023","article-title":"Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies.","volume":"122","author":"Stahl","year":"2010","journal-title":"J Affect Disord"},{"key":"R63-3-20210129","first-page":"470","article-title":"Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome J Clin P","volume":"32","author":"Lombardo","year":"2012","journal-title":"sychopharmacol"},{"key":"R64-3-20210129","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jad.2007.08.015","article-title":"3rd, Carlson B. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.","volume":"107","author":"Suppes","year":"2008","journal-title":"J Affect Disord"},{"key":"R65-3-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","article-title":"Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.","volume":"28","author":"Thase","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"R66-3-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v61n0307","article-title":"Clinical predictors of acute response with quetiapine in psychotic mood disorders.","volume":"61","author":"Zarate","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"R67-3-20210129","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.","volume":"67","author":"Bowden","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R68-3-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-5618.2003.02237.x","article-title":"Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania.","volume":"5","author":"Chengappa","year":"2003","journal-title":"Bipolar Disord"},{"key":"R69-3-20210129","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R70-3-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.08m04411gry","article-title":"Case reports of postmarketing adverse event experiences with olanzapine intramuscular treatment in patients with agitation.","volume":"71","author":"Marder","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R72-3-20210129","first-page":"453","article-title":"A comparison of two adjunctive treatment strategies in acute mania.","volume":"50","author":"Busch","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"R74-3-20210129","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.ajp.161.1.3","article-title":"What is a mood stabilizer An evidence-based response.","volume":"161","author":"Bauer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R75-3-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2010.00861.x","article-title":"From BALANCE to DSM-5: taking lithium seriously.","volume":"12","author":"Ghaemi","year":"2010","journal-title":"Bipolar Disord"},{"key":"R76-3-20210129","first-page":"819","article-title":"Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers CNS D","volume":"25","author":"Goodwin","year":"2011","journal-title":"rugs"},{"key":"R77-3-20210129","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1001\/jama.290.11.1467","article-title":"Suicide risk in bipolar disorder during treatment with lithium and divalproex.","volume":"290","author":"Goodwin","year":"2003","journal-title":"JAMA"},{"key":"R78-3-20210129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1399-5618.2006.00344.x","article-title":"Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review.","volume":"8","author":"Baldessarini","year":"2006","journal-title":"Bipolar Disord"},{"key":"R79-3-20210129","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","article-title":"Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials.","volume":"162","author":"Cipriani","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R80-3-20210129","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1055\/s-2001-15878","article-title":"Does lithium exert an independent antisuicidal effect P","volume":"34","author":"Ahrens","year":"2001","journal-title":"harmacopsychiatry"},{"key":"R81-3-20210129","doi-asserted-by":"crossref","first-page":"916","DOI":"10.4088\/JCP.v69n0605","article-title":"Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.","volume":"69","author":"Marangell","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R82-3-20210129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1017\/S1461145710000404","article-title":"Excellent lithium responders have normal cognitive functions and plasma BDNF levels.","volume":"13","author":"Rybakowski","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"R83-3-20210129","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/npp.2010.41","article-title":"Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study.","volume":"35","author":"Lyoo","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"R84-3-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4088\/JCP.07m03745","article-title":"A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.","volume":"70","author":"Moore","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"R85-3-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1503\/jpn.110097","article-title":"Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study.","volume":"37","author":"Hajek","year":"2012","journal-title":"J Psychiatry Neurosci"},{"key":"R86-3-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1399-5618.2012.01013.x","article-title":"Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment.","volume":"14","author":"Hajek","year":"2012","journal-title":"Bipolar Disord"},{"key":"R87-3-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1503\/jpn.110143","article-title":"Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis.","volume":"37","author":"Hajek","year":"2012","journal-title":"J Psychiatry Neurosci"},{"key":"R88-3-20210129","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.npp.1301233","article-title":"Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys.","volume":"32","author":"Konopaske","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"R89-3-20210129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.biopsych.2007.08.018","article-title":"Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys.","volume":"63","author":"Konopaske","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R90-3-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.","volume":"68","author":"Ho","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"R91-3-20210129","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1017\/S0033291712001948","article-title":"Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study.","volume":"43","author":"Mora","year":"2013","journal-title":"Psychol Med"},{"key":"R92-3-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1176\/ps.2007.58.1.85","article-title":"Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.","volume":"58","author":"Baldessarini","year":"2007","journal-title":"Psychiatr Serv"},{"key":"R93-3-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1192\/bjp.bp.110.084822","article-title":"Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study.","volume":"199","author":"Kessing","year":"2011","journal-title":"Br J Psychiatry"},{"key":"R94-3-20210129","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0893-133X(01)00390-6","article-title":"Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania.","volume":"26","author":"Swann","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"R95-3-20210129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ajmg.10360","article-title":"Endophenotypes in bipolar disorder.","volume":"114","author":"Lenox","year":"2002","journal-title":"Am J Med Genet"},{"key":"R96-3-20210129","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"R97-3-20210129","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1034\/j.1600-0447.2003.00126.x","article-title":"Rapid-cycling bipolar disorder: effects of long-term treatments.","volume":"108","author":"Tondo","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"R98-3-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0165-0327(99)00196-2","article-title":"Effects of rapid cycling on response to lithium maintenance treatment in 360 bipolar I and II disorder patients.","volume":"61","author":"Baldessarini","year":"2000","journal-title":"J Affect Disord"},{"key":"R99-3-20210129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.eurpsy.2004.12.003","article-title":"New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder.","volume":"20","author":"Calabrese","year":"2005","journal-title":"Eur Psychiatry"},{"key":"R100-3-20210129","doi-asserted-by":"crossref","first-page":"815","DOI":"10.4088\/JCP.v60n1202","article-title":"Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients.","volume":"60","author":"Hirschfeld","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R101-3-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004583-200006000-00009","article-title":"Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.","volume":"39","author":"Kowatch","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R102-3-20210129","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/10673229309017072","article-title":"Discontinuation of maintenance treatment in bipolar disorder: risks and implications.","volume":"1","author":"Suppes","year":"1993","journal-title":"Harv Rev Psychiatry"},{"key":"R103-3-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.164.2.149","article-title":"Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder.","volume":"164","author":"Goodwin","year":"1994","journal-title":"Br J Psychiatry"},{"key":"R104-3-20210129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1600-0447.2003.00274.x","article-title":"Relapse into mania or depression following lithium discontinuation: a 7-year follow-up.","volume":"109","author":"Cavanagh","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"R105-3-20210129","first-page":"231","article-title":"What is the optimal serum lithium level in the long-term treatment of bipolar disordera review Bipolar D","volume":"10","author":"Severus","year":"2008","journal-title":"isord"},{"key":"R106-3-20210129","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1017\/S1461145709991246","article-title":"Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.","volume":"13","author":"Tamayo","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"R107-3-20210129","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/CHI.0b013e31819c55ec","article-title":"A double-blind randomized, placebo-controlled trial of divalproex extended-release in the treatment of bipolar disorder in children and adolescents.","volume":"48","author":"Wagner","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R108-3-20210129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4088\/JCP.08m04960yel","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.","volume":"71","author":"Hirschfeld","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"R109-3-20210129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(09)61828-6","article-title":"Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial.","volume":"375","author":"Geddes","year":"2010","journal-title":"Lancet"},{"key":"R110-3-20210129","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bdi.12027","article-title":"The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144).","volume":"15","author":"Nolen","year":"2013","journal-title":"Bipolar Disord"},{"key":"R111-3-20210129","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/01.jcp.0000144887.66319.2f","article-title":"Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania.","volume":"24","author":"Yatham","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R112-3-20210129","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis.","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet"},{"key":"R113-3-20210129","first-page":"690","article-title":"Is the safety of lithium no longer in the balance L","volume":"379","author":"Malhi","year":"2012","journal-title":"ancet"},{"key":"R114-3-20210129","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.","volume":"66","author":"Bowden","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R115-3-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2009.03.025","article-title":"Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.","volume":"111","author":"Patel","year":"2009","journal-title":"Schizophr Res"},{"key":"R116-3-20210129","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ki.2009.433","article-title":"Renal failure occurs in chronic lithium treatment but is uncommon.","volume":"77","author":"Bendz","year":"2010","journal-title":"Kidney Int"},{"key":"R117-3-20210129","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"R118-3-20210129","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-5618.2010.00798.x","article-title":"Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials.","volume":"12","author":"Correll","year":"2010","journal-title":"Bipolar Disord"},{"key":"R119-3-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.euroneuro.2012.05.017","article-title":"Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania.","volume":"23","author":"Goikolea","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"R121-3-20210129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.161.1.169","article-title":"Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients.","volume":"161","author":"Zarate","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R123-3-20210129","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4088\/JCP.v66n0809","article-title":"Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy.","volume":"66","author":"Gopal","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"R124-3-20210129","first-page":"CD004043","article-title":"Risperidone alone or in combination for acute mania.","author":"Rendell","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R125-3-20210129","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jad.2009.08.013","article-title":"Olanzapine vs. lithium in management of acute mania.","volume":"122","author":"Shafti","year":"2010","journal-title":"J Affect Disord"},{"key":"R126-3-20210129","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archgenpsychiatry.2011.72","article-title":"Chronic divalproex sodium failed to attenuate agitation and clinical progression of Alzheimer disease.","volume":"68","author":"Tariot","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"R127-3-20210129","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","article-title":"Chronic divalproex sodium use and brain atrophy in Alzheimer disease.","volume":"77","author":"Fleisher","year":"2011","journal-title":"Neurology"},{"key":"R128-3-20210129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania. A placebo-controlled study.","volume":"48","author":"Pope","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"R129-3-20210129","first-page":"167","article-title":"DEWIPAa standardized questionnaire for assessing knowledge about symptoms, etiology and psychopharmacologic treatment in patients with depressive episodes.","volume":"26","author":"Muller","year":"1999","journal-title":"Psychiatr Prax"},{"key":"R130-3-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S1461145712000491","article-title":"A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression.","volume":"16","author":"Reinares","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"R131-3-20210129","first-page":"115","article-title":"Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women Prog Neuropsychopharmacol Biol P","volume":"27","author":"Akdeniz","year":"2003","journal-title":"sychiatry"},{"key":"R132-3-20210129","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/JCP.0b013e31820f4f9e","article-title":"Rapid development of severe hypertriglyceridemia and hypercholesterolemia during augmentation of quetiapine with valproic acid.","volume":"31","author":"Liang","year":"2011","journal-title":"J Clin Psychopharmacol"},{"key":"R133-3-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0447.2009.01368.x","article-title":"Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial.","volume":"120","author":"Behzadi","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"R134-3-20210129","doi-asserted-by":"crossref","first-page":"668","DOI":"10.4088\/JCP.v65n0511","article-title":"A 6-month, multicenter, open-label evaluation of beaded, extended-release carbamazepine capsule monotherapy in bipolar disorder patients with manic or mixed episodes.","volume":"65","author":"Ketter","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R135-3-20210129","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/YCT.0b013e3181e6332e","article-title":"Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder: a systematic review.","volume":"27","author":"Versiani","year":"2011","journal-title":"J ECT"},{"key":"R136-3-20210129","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/archpsyc.1988.01800320037004","article-title":"Electroconvulsive treatment compared with lithium in the management of manic states.","volume":"45","author":"Small","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R137-3-20210129","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-0327(82)90038-6","article-title":"The treatment of mania. A retrospective evaluation of the effects of ECT, chlorpromazine, and lithium.","volume":"4","author":"Thomas","year":"1982","journal-title":"J Affect Disord"},{"key":"R138-3-20210129","first-page":"245","article-title":"ECT versus chlorpromazine in mania.","volume":"12","author":"McCabe","year":"1977","journal-title":"Biol Psychiatry"},{"key":"R139-3-20210129","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/cns.12017","article-title":"Combination therapy for manic phases: a critical review of a common practice.","volume":"18","author":"Geoffroy","year":"2012","journal-title":"CNS Neurosci Ther"},{"key":"R140-3-20210129","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14740338.2012.683523","article-title":"Safety and tolerability of antipsychotic polypharmacy.","volume":"11","author":"Gallego","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"R141-3-20210129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hup.990","article-title":"Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials.","volume":"24","author":"Ceron-Litvoc","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"R142-3-20210129","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/JCP.v58n1102","article-title":"Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.","volume":"58","author":"Denicoff","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"R143-3-20210129","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4088\/JCP.v66n0204","article-title":"Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients.","volume":"66","author":"Baethge","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R144-3-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archpsyc.1984.01790130061009","article-title":"Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.","volume":"41","author":"Klein","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"R145-3-20210129","first-page":"265","article-title":"Lithium combined with carbamazepine or haloperidol in the treatment of mania.","volume":"31","author":"Small","year":"1995","journal-title":"Psychopharmacol Bull"},{"key":"R146-3-20210129","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials.","volume":"67","author":"Perlis","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R147-3-20210129","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1744-859X-8-16","article-title":"Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.","volume":"8","author":"Fountoulakis","year":"2009","journal-title":"Ann Gen Psychiatry"},{"key":"R148-3-20210129","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproatelithium monotherapy: a placebo-controlled study.","volume":"165","author":"Vieta","year":"2008","journal-title":"Am J Psychiatry"},{"key":"R149-3-20210129","doi-asserted-by":"crossref","first-page":"e1000434","DOI":"10.1371\/journal.pmed.1000434","article-title":"Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.","volume":"8","author":"Tsai","year":"2011","journal-title":"PLoS Med"},{"key":"R150-3-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.","volume":"160","author":"Keck","year":"2003","journal-title":"Am J Psychiatry"},{"key":"R151-3-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":"Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial.","volume":"25","author":"Potkin","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R152-3-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0269881108099418","article-title":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study.","volume":"24","author":"Vieta","year":"2010","journal-title":"J Psychopharmacol"},{"key":"R153-3-20210129","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4088\/JCP.11m07389","article-title":"Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection.","volume":"73","author":"Sachs","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"R154-3-20210129","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4088\/JCP.11m07388","article-title":"Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.","volume":"73","author":"Sachs","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"R155-3-20210129","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1097\/JCP.0b013e318270dea9","article-title":"Enhanced ziprasidone combination therapy effectiveness in obese compared to nonobese patients with bipolar disorder.","volume":"32","author":"Miller","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"R156-3-20210129","doi-asserted-by":"crossref","first-page":"e34757","DOI":"10.1371\/journal.pone.0034757","article-title":"A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state.","volume":"7","author":"Patkar","year":"2012","journal-title":"PLoS One"},{"key":"R157-3-20210129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JCP.0b013e31823f872f","article-title":"Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension.","volume":"32","author":"Szegedi","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"R158-3-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1755-5949.2010.00200.x","article-title":"Asenapine: a review of acute and extension phase data in bipolar disorder.","volume":"17","author":"McIntyre","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"R159-3-20210129","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jad.2010.04.005","article-title":"Asenapine for long-term treatment of bipolar disorder: a double-blind 40-week extension study.","volume":"126","author":"McIntyre","year":"2010","journal-title":"J Affect Disord"},{"key":"R160-3-20210129","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial.","volume":"122","author":"McIntyre","year":"2010","journal-title":"J Affect Disord"},{"key":"R161-3-20210129","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord"},{"key":"R162-3-20210129","first-page":"411","article-title":"Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.","volume":"52","author":"McElroy","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"R163-3-20210129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1176\/ajp.153.6.759","article-title":"Clozapine for treatment-refractory mania.","volume":"153","author":"Calabrese","year":"1996","journal-title":"Am J Psychiatry"},{"key":"R164-3-20210129","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004850-199703000-00006","article-title":"Response to clozapine in acute mania is more rapid than that of chlorpromazine.","volume":"12","author":"Barbini","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"R165-3-20210129","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.","volume":"156","author":"Suppes","year":"1999","journal-title":"Am J Psychiatry"},{"key":"R167-3-20210129","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4088\/JCP.v64n0707","article-title":"Levetiracetam in the treatment of acute mania: an open add-on study with an on-off-on design.","volume":"64","author":"Grunze","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R168-3-20210129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00213-008-1109-8","article-title":"Levetiracetam as monotherapy or add-on to valproate in the treatment of acute maniaa randomized open-label study.","volume":"198","author":"Kruger","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"R169-3-20210129","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/ajp.2006.163.7.1179","article-title":"A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents.","volume":"163","author":"Wagner","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R170-3-20210129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145708008596","article-title":"A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.","volume":"11","author":"Vieta","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"R171-3-20210129","first-page":"CD004857","article-title":"Oxcarbazepine for acute affective episodes in bipolar disorder.","author":"Vasudev","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R172-3-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.","volume":"8","author":"Kushner","year":"2006","journal-title":"Bipolar Disord"},{"key":"R173-3-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10673220903129814","article-title":"Anticonvulsants in the treatment of major depressive disorder: an overview.","volume":"17","author":"Vigo","year":"2009","journal-title":"Harv Rev Psychiatry"},{"key":"R174-3-20210129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1744-859X-4-5","article-title":"Review of the use of topiramate for treatment of psychiatric disorders.","volume":"4","author":"Arnone","year":"2005","journal-title":"Ann Gen Psychiatry"},{"key":"R175-3-20210129","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/NDT.S3135","article-title":"Amisulpride plus valproate vs haloperidol plus valproate in the treatment of acute mania of bipolar I patients: a multicenter, open-label, randomized, comparative trial.","volume":"4","author":"Thomas","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"R176-3-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jad.2010.09.011","article-title":"Paliperidone XR as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.","volume":"129","author":"Berwaerts","year":"2011","journal-title":"J Affect Disord"},{"key":"R177-3-20210129","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v69n0806","article-title":"A double-blind, randomized, placebo-controlled 4-week study on the efficacy and safety of the purinergic agents allopurinol and dipyridamole adjunctive to lithium in acute bipolar mania.","volume":"69","author":"Machado-Vieira","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R178-3-20210129","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-5618.2012.01001.x","article-title":"Allopurinol augmentation in the outpatient treatment of bipolar mania: a pilot study.","volume":"14","author":"Fan","year":"2012","journal-title":"Bipolar Disord"},{"key":"R179-3-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-5618.2006.00363.x","article-title":"Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.","volume":"8","author":"Akhondzadeh","year":"2006","journal-title":"Bipolar Disord"},{"key":"R180-3-20210129","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.plefa.2009.10.007","article-title":"Is aspirin useful in patients on lithium A pharmacoepidemiological study related to bipolar disorder.","volume":"82","author":"Stolk","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"R181-3-20210129","first-page":"CD005169","article-title":"Omega-3 fatty acids for bipolar disorder.","author":"Montgomery","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"R182-3-20210129","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/JCP.0b013e318266854c","article-title":"Omega-3 fatty acid treatment, with or without cytidine, fails to show therapeutic properties in bipolar disorder: a double-blind, randomized add-on clinical trial.","volume":"32","author":"Murphy","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"R183-3-20210129","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archgenpsychiatry.2007.43","article-title":"Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen.","volume":"65","author":"Yildiz","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"R184-3-20210129","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.psyneuen.2005.11.001","article-title":"A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder.","volume":"31","author":"Kulkarni","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"R185-3-20210129","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1399-5618.2007.00530.x","article-title":"Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study.","volume":"9","author":"Zarate","year":"2007","journal-title":"Bipolar Disord"},{"key":"R186-3-20210129","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jad.2010.08.015","article-title":"Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania.","volume":"129","author":"Amrollahi","year":"2011","journal-title":"J Affect Disord"},{"key":"R187-3-20210129","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.PSYPHR.0000413086.80585.ce","article-title":"Review of transcranial magnetic stimulation for bipolar disorder.","volume":"47","author":"Gilmer","year":"2012","journal-title":"Psychopharm Rev"},{"key":"R188-3-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord"},{"key":"R189-3-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second editionrecommendations from the British Association for Psychopharmacology.","volume":"23","year":"2009","journal-title":"J Psychopharmacol"},{"key":"R190-3-20210129","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"; Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.","volume":"66","author":"Suppes","year":"2005","journal-title":"J Clin Psychiatry"}],"container-title":["Harvard Review of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HRP.0000000000000018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T11:04:27Z","timestamp":1689505467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00023727-201409000-00003"}},"subtitle":["An Algorithm for Acute Mania"],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":176,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/hrp.0000000000000018","relation":{},"ISSN":["1067-3229"],"issn-type":[{"value":"1067-3229","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}